Mark Kamps

Title(s)Emeritus Professor, Pathology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Molecular Pathology of Cancer Training Grant
    NIH T32CA077109Jul 1, 1998 - Jul 31, 2010
    Role: Principal Investigator
    VEGF MRNA STABILIZATION BY HYPOXIA AND TUMOR MUTATIONS
    NIH R01HL054451Jun 1, 1995 - May 31, 1999
    Role: Principal Investigator
    Hoxa9, Meis1, and Pbx in Self-renewal and Leukemogenesis
    NIH R01CA056876Apr 10, 1992 - Nov 30, 2013
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy. Cancer Med. 2019 Sep; 8(11):5274-5288. Watanabe A, Inukai T, Kagami K, Abe M, Takagi M, Fukushima T, Fukushima H, Nanmoku T, Terui K, Ito T, Toki T, Ito E, Fujimura J, Goto H, Endo M, Look T, Kamps M, Minegishi M, Takita J, Inaba T, Takahashi H, Ohara A, Harama D, Shinohara T, Somazu S, Oshiro H, Akahane K, Goi K, Sugita K. PMID: 31305009; PMCID: PMC6718581.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    2. Comprehensive characterization of neutrophil genome topology. Genes Dev. 2017 01 15; 31(2):141-153. Zhu Y, Gong K, Denholtz M, Chandra V, Kamps MP, Alber F, Murre C. PMID: 28167501; PMCID: PMC5322729.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    3. Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model. Blood. 2012 Dec 06; 120(24):4712-9. Li D, Yang H, Nan H, Liu P, Pang S, Zhao Q, Karni R, Kamps MP, Xu Y, Zhou J, Wiedmer T, Sims PJ, Wang F. PMID: 23086752; PMCID: PMC3520617.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    4. The plasminogen receptor, Plg-R(KT), and macrophage function. J Biomed Biotechnol. 2012; 2012:250464. Miles LA, Lighvani S, Baik N, Andronicos NM, Chen EI, Parmer CM, Khaldoyanidi S, Diggs JE, Kiosses WB, Kamps MP, Yates JR, Parmer RJ. PMID: 23125524; PMCID: PMC3484331.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    5. NSD1 PHD domains bind methylated H3K4 and H3K9 using interactions disrupted by point mutations in human sotos syndrome. Hum Mutat. 2011 Mar; 32(3):292-8. Pasillas MP, Shah M, Kamps MP. PMID: 21972110.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    6. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev. 2009 Dec 15; 23(24):2824-38. Xu J, Watts JA, Pope SD, Gadue P, Kamps M, Plath K, Zaret KS, Smale ST. PMID: 20008934; PMCID: PMC2800090.
      View in: PubMed   Mentions: 101     Fields:    Translation:AnimalsCells
    7. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood. 2010 Feb 18; 115(7):1319-30. Andronicos NM, Chen EI, Baik N, Bai H, Parmer CM, Kiosses WB, Kamps MP, Yates JR, Parmer RJ, Miles LA. PMID: 19897580; PMCID: PMC2826757.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    8. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1. Leuk Lymphoma. 2009 May; 50(5):816-28. Scheele JS, Kolanczyk M, Gantert M, Zemojtel T, Dorn A, Sykes DB, Sykes DP, Möbest DC, Kamps MP, Räpple D, Duchniewicz M. PMID: 19399691.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    9. PBX1 is dispensable for neural commitment of RA-treated murine ES cells. In Vitro Cell Dev Biol Anim. 2009 May-Jun; 45(5-6):252-63. Jürgens AS, Kolanczyk M, Moebest DC, Zemojtel T, Lichtenauer U, Duchniewicz M, Gantert MP, Hecht J, Hattenhorst U, Burdach S, Dorn A, Kamps MP, Beuschlein F, Räpple D, Scheele JS. PMID: 19148706; PMCID: PMC2758398.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    10. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol. 2007 Jul; 9(7):804-12. Wang GG, Cai L, Pasillas MP, Kamps MP. PMID: 17589499.
      View in: PubMed   Mentions: 211     Fields:    Translation:HumansAnimalsCells
    11. Quantitative expansion of ES cell-derived myeloid progenitors capable of differentiating into macrophages. J Leukoc Biol. 2007 Mar; 81(3):711-9. Odegaard JI, Vats D, Zhang L, Ricardo-Gonzalez R, Smith KL, Sykes DB, Kamps MP, Chawla A. PMID: 17158607; PMCID: PMC1904487.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    12. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology. 2007 Feb; 148(2):693-704. Lichtenauer UD, Duchniewicz M, Kolanczyk M, Hoeflich A, Hahner S, Else T, Bicknell AB, Zemojtel T, Stallings NR, Schulte DM, Kamps MP, Hammer GD, Scheele JS, Beuschlein F. PMID: 17082260.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    13. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Mol Cell Biol. 2006 May; 26(10):3902-16. Wang GG, Pasillas MP, Kamps MP. PMID: 16648484; PMCID: PMC1488994.
      View in: PubMed   Mentions: 50     Fields:    Translation:AnimalsCells
    14. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nat Methods. 2006 Apr; 3(4):287-93. Wang GG, Calvo KR, Pasillas MP, Sykes DB, Häcker H, Kamps MP. PMID: 16554834.
      View in: PubMed   Mentions: 206     Fields:    Translation:AnimalsCells
    15. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 2006 Jan 12; 439(7073):204-7. Häcker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, Raz E, Wagner H, Häcker G, Mann M, Karin M. PMID: 16306937.
      View in: PubMed   Mentions: 388     Fields:    Translation:AnimalsCells
    16. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood. 2005 Jul 01; 106(1):254-64. Wang GG, Pasillas MP, Kamps MP. PMID: 15755900; PMCID: PMC1895124.
      View in: PubMed   Mentions: 65     Fields:    Translation:AnimalsCells
    17. TALE homeodomain proteins regulate gonadotropin-releasing hormone gene expression independently and via interactions with Oct-1. J Biol Chem. 2004 Jul 16; 279(29):30287-97. Rave-Harel N, Givens ML, Nelson SB, Duong HA, Coss D, Clark ME, Hall SB, Kamps MP, Mellon PL. PMID: 15138251; PMCID: PMC2935805.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    18. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice. Mol Cell Biol. 2004 Feb; 24(3):1256-69. Sykes DB, Kamps MP. PMID: 14729970; PMCID: PMC321418.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    19. Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-Pbx1 oncoprotein. Leuk Lymphoma. 2003 Jul; 44(7):1187-99. Sykes DB, Scheele J, Pasillas M, Kamps MP. PMID: 12916872.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    20. Estrogen-regulated conditional oncoproteins: tools to address open questions in normal myeloid cell function, normal myeloid differentiation, and the genetic basis of differentiation arrest in myeloid leukemia. Leuk Lymphoma. 2003 Jul; 44(7):1131-9. Sykes DB, Kamps MP. PMID: 12916864.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    21. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene. 2002 Jun 20; 21(27):4247-56. Calvo KR, Sykes DB, Pasillas MP, Kamps MP. PMID: 12082612.
      View in: PubMed   Mentions: 50     Fields:    Translation:AnimalsCells
    22. An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. Cell. 2002 Apr 19; 109(2):169-80. Klappacher GW, Lunyak VV, Sykes DB, Sawka-Verhelle D, Sage J, Brard G, Ngo SD, Gangadharan D, Jacks T, Kamps MP, Rose DW, Rosenfeld MG, Glass CK. PMID: 12007404.
      View in: PubMed   Mentions: 52     Fields:    Translation:AnimalsCells
    23. Meis1a suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc Natl Acad Sci U S A. 2001 Nov 06; 98(23):13120-5. Calvo KR, Knoepfler PS, Sykes DB, Pasillas MP, Kamps MP. PMID: 11687616; PMCID: PMC60834.
      View in: PubMed   Mentions: 41     Fields:    Translation:AnimalsCells
    24. HoxB8 requires its Pbx-interaction motif to block differentiation of primary myeloid progenitors and of most cell line models of myeloid differentiation. Oncogene. 2001 Sep 06; 20(39):5440-8. Knoepfler PS, Sykes DB, Pasillas M, Kamps MP. PMID: 11571641.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    25. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression. Mol Cell Biol. 2000 May; 20(9):3274-85. Calvo KR, Sykes DB, Pasillas M, Kamps MP. PMID: 10757811; PMCID: PMC85621.
      View in: PubMed   Mentions: 58     Fields:    Translation:AnimalsCells
    26. Direct interaction of two homeoproteins, homothorax and extradenticle, is essential for EXD nuclear localization and function. Mech Dev. 2000 Mar 01; 91(1-2):279-91. Jaw TJ, You LR, Knoepfler PS, Yao LC, Pai CY, Tang CY, Chang LP, Berthelsen J, Blasi F, Kamps MP, Sun YH. PMID: 10704852.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    27. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1. Oncogene. 1999 Dec 23; 18(56):8033-43. Calvo KR, Knoepfler P, McGrath S, Kamps MP. PMID: 10637514.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    28. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Res. 1999 Sep 15; 27(18):3752-61. Knoepfler PS, Bergstrom DA, Uetsuki T, Dac-Korytko I, Sun YH, Wright WE, Tapscott SJ, Kamps MP. PMID: 10471746; PMCID: PMC148632.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    29. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1. Oncogene. 1999 Sep 02; 18(35):4920-9. Fu X, McGrath S, Pasillas M, Nakazawa S, Kamps MP. PMID: 10490826.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    30. mAngiogenin-3, a target gene of oncoprotein E2a-Pbx1, encodes a new angiogenic member of the angiogenin family. Growth Factors. 1999; 17(2):125-37. Fu X, Roberts WG, Nobile V, Shapiro R, Kamps MP. PMID: 10595312.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    31. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc Natl Acad Sci U S A. 1997 Dec 23; 94(26):14553-8. Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP. PMID: 9405651; PMCID: PMC25052.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansAnimalsCells
    32. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements. Oncogene. 1997 May 29; 14(21):2521-31. Knoepfler PS, Kamps MP. PMID: 9191052.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    33. The Pbx family of proteins is strongly upregulated by a post-transcriptional mechanism during retinoic acid-induced differentiation of P19 embryonal carcinoma cells. Mech Dev. 1997 Apr; 63(1):5-14. Knoepfler PS, Kamps MP. PMID: 9178252.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    34. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol Cell Biol. 1997 Mar; 17(3):1503-12. Fu X, Kamps MP. PMID: 9032278; PMCID: PMC231876.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    35. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo. Oncogene. 1997 Jan 09; 14(1):75-83. Lu Q, Kamps MP. PMID: 9010234.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    36. VEGF mRNA is stabilized by ras and tyrosine kinase oncogenes, as well as by UV radiation--evidence for divergent stabilization pathways. Growth Factors. 1997; 14(2-3):199-212. White FC, Benehacene A, Scheele JS, Kamps M. PMID: 9255609.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    37. E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation. Curr Top Microbiol Immunol. 1997; 220:25-43. Kamps MP. PMID: 9103673.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    38. Pbx-1 Hox heterodimers bind DNA on inseparable half-sites that permit intrinsic DNA binding specificity of the Hox partner at nucleotides 3' to a TAAT motif. Nucleic Acids Res. 1996 Jun 15; 24(12):2288-94. Knoepfler PS, Lu Q, Kamps MP. PMID: 8710498; PMCID: PMC145957.
      View in: PubMed   Mentions: 27     Fields:    Translation:Cells
    39. Structural determinants within Pbx1 that mediate cooperative DNA binding with pentapeptide-containing Hox proteins: proposal for a model of a Pbx1-Hox-DNA complex. Mol Cell Biol. 1996 Apr; 16(4):1632-40. Lu Q, Kamps MP. PMID: 8657138; PMCID: PMC231149.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    40. Selective repression of transcriptional activators by Pbx1 does not require the homeodomain. Proc Natl Acad Sci U S A. 1996 Jan 09; 93(1):470-4. Lu Q, Kamps MP. PMID: 8552663; PMCID: PMC40260.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    41. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene. 1996 Jan 04; 12(1):19-30. Kamps MP, Wright DD, Lu Q. PMID: 8552391.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    42. The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Mol Cell Biol. 1995 Dec; 15(12):7091-7. Peers B, Sharma S, Johnson T, Kamps M, Montminy M. PMID: 8524276; PMCID: PMC230964.
      View in: PubMed   Mentions: 45     Fields:    Translation:AnimalsCells
    43. Protein kinase A-dependent transactivation by the E2A-Pbx1 fusion protein. J Biol Chem. 1995 Oct 27; 270(43):25340-3. Ogo A, Waterman MR, Kamps MP, Kagawa N. PMID: 7592695.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    44. The pentapeptide motif of Hox proteins is required for cooperative DNA binding with Pbx1, physically contacts Pbx1, and enhances DNA binding by Pbx1. Mol Cell Biol. 1995 Oct; 15(10):5811-9. Knoepfler PS, Kamps MP. PMID: 7565734; PMCID: PMC230833.
      View in: PubMed   Mentions: 59     Fields:    Translation:AnimalsCells
    45. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Mol Cell Biol. 1995 Jul; 15(7):3786-95. Lu Q, Knoepfler PS, Scheele J, Wright DD, Kamps MP. PMID: 7791786; PMCID: PMC230617.
      View in: PubMed   Mentions: 47     Fields:    Translation:AnimalsCells
    46. VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines. Growth Factors. 1995; 12(4):289-301. White FC, Carroll SM, Kamps MP. PMID: 8930020.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    47. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence. Oncogene. 1994 Nov; 9(11):3159-66. Kamps MP, Wright DD. PMID: 7936638.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    48. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol Cell Biol. 1994 Jun; 14(6):3938-48. Lu Q, Wright DD, Kamps MP. PMID: 7910944; PMCID: PMC358760.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    49. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia. Mol Cell Biol. 1994 Apr; 14(4):2429-37. Wright DD, Sefton BM, Kamps MP. PMID: 8139546; PMCID: PMC358610.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    50. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol. 1993 Jan; 13(1):351-7. Kamps MP, Baltimore D. PMID: 8093327; PMCID: PMC358914.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    51. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood. 1992 Apr 01; 79(7):1781-8. Privitera E, Kamps MP, Hayashi Y, Inaba T, Shapiro LH, Raimondi SC, Behm F, Hendershot L, Carroll AJ, Baltimore D, et al. PMID: 1348433.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    52. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev. 1991 Mar; 5(3):358-68. Kamps MP, Look AT, Baltimore D. PMID: 1672117.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    53. Generation and use of anti-phosphotyrosine antibodies for immunoblotting. Methods Enzymol. 1991; 201:101-10. Kamps MP. PMID: 1719339.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    54. The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2. Mol Cell Biol. 1990 Oct; 10(10):5464-72. Kamps MP, Corcoran L, LeBowitz JH, Baltimore D. PMID: 2204815; PMCID: PMC361254.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    55. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell. 1990 Feb 23; 60(4):547-55. Kamps MP, Murre C, Sun XH, Baltimore D. PMID: 1967983.
      View in: PubMed   Mentions: 191     Fields:    Translation:HumansCells
    56. pp60c-src activation in human colon carcinoma. J Clin Invest. 1989 Jun; 83(6):2025-33. Cartwright CA, Kamps MP, Meisler AI, Pipas JM, Eckhart W. PMID: 2498394; PMCID: PMC303927.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    57. Acid and base hydrolysis of phosphoproteins bound to immobilon facilitates analysis of phosphoamino acids in gel-fractionated proteins. Anal Biochem. 1989 Jan; 176(1):22-7. Kamps MP, Sefton BM. PMID: 2540676.
      View in: PubMed   Mentions: 122     Fields:    Translation:AnimalsCells
    58. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo. Mol Cell Biol. 1988 Sep; 8(9):3969-73. Stern DF, Kamps MP, Cao H. PMID: 2464744; PMCID: PMC365461.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    59. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Oncogene Res. 1988 Sep; 3(2):105-15. Kamps MP, Sefton BM. PMID: 2465525.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    60. fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell. 1988 Aug 12; 54(4):553-60. Sassone-Corsi P, Lamph WW, Kamps M, Verma IM. PMID: 3135941.
      View in: PubMed   Mentions: 132     Fields:    Translation:Cells
    61. Monoclonal antibodies to phosphotyrosine. J Immunol Methods. 1988 May 09; 109(2):277-85. Glenney JR, Zokas L, Kamps MP. PMID: 2452204.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    62. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Oncogene. 1988 Apr; 2(4):305-15. Kamps MP, Sefton BM. PMID: 2452398.
      View in: PubMed   Mentions: 134     Fields:    Translation:AnimalsCells
    63. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions. EMBO J. 1988 Apr; 7(4):995-1001. Stern DF, Kamps MP. PMID: 3261240; PMCID: PMC454426.
      View in: PubMed   Mentions: 65     Fields:    Translation:AnimalsCells
    64. The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity. J Virol. 1986 May; 58(2):468-74. Buss JE, Kamps MP, Gould K, Sefton BM. PMID: 3009860; PMCID: PMC252933.
      View in: PubMed   Mentions: 70     Fields:    Translation:AnimalsCells
    65. Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation. Cell. 1986 Apr 11; 45(1):105-12. Kamps MP, Buss JE, Sefton BM. PMID: 3006923.
      View in: PubMed   Mentions: 79     Fields:    Translation:AnimalsCells
    66. Neither arginine nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src. Mol Cell Biol. 1986 Mar; 6(3):751-7. Kamps MP, Sefton BM. PMID: 2430174; PMCID: PMC367575.
      View in: PubMed   Mentions: 60     Fields:    Translation:AnimalsCells
    67. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc Natl Acad Sci U S A. 1985 Jul; 82(14):4625-8. Kamps MP, Buss JE, Sefton BM. PMID: 2991884; PMCID: PMC390438.
      View in: PubMed   Mentions: 158     Fields:    Translation:AnimalsCells
    68. Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein. Mol Cell Biol. 1984 Dec; 4(12):2697-704. Buss JE, Kamps MP, Sefton BM. PMID: 6441887; PMCID: PMC369279.
      View in: PubMed   Mentions: 74     Fields:    Translation:AnimalsCells
    69. Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites. Nature. 1984 Aug 16-22; 310(5978):589-92. Kamps MP, Taylor SS, Sefton BM. PMID: 6431300.
      View in: PubMed   Mentions: 104     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Mark's Networks
    Concepts (410)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (14)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California